Health Care

Notable mergers and acquisitions moves in 2022

With another year of deal-making rapidly coming to a close, FOX Business takes a look at some of 2022's notable M&A activity in sectors including tech, health care and real estate.

Amgen to buy Horizon Therapeutics for $26.4B

Amgen Inc. announced on Monday that it will acquire Horizon Therapeutics for $26 billion to further grow the company’s medical legacy. Horizon's best-selling drug is Tepezza.